{"pmid":32314951,"title":"Opioid use disorder and the COVID 19 pandemic: A call to sustain regulatory easements and further expand access to treatment.","text":["Opioid use disorder and the COVID 19 pandemic: A call to sustain regulatory easements and further expand access to treatment.","We highlight the critical roles that pharmacists have related to sustaining and advancing the changes being made in the face of the current COVID-19 pandemic to ensure that patients have more seamless and less complex access to treatment. Discussed herein is how the current COVID-19 pandemic is impacting persons with substance use disorders, barriers that persist, and the opportunities that arise as regulations around treatments for this population are eased.","Subst Abus","Green, Traci C","Bratberg, Jeffrey","Finnell, Deborah S","32314951"],"abstract":["We highlight the critical roles that pharmacists have related to sustaining and advancing the changes being made in the face of the current COVID-19 pandemic to ensure that patients have more seamless and less complex access to treatment. Discussed herein is how the current COVID-19 pandemic is impacting persons with substance use disorders, barriers that persist, and the opportunities that arise as regulations around treatments for this population are eased."],"journal":"Subst Abus","authors":["Green, Traci C","Bratberg, Jeffrey","Finnell, Deborah S"],"date":"2020-04-22T11:00:00Z","year":2020,"_id":"32314951","week":"202017|Apr 20 - Apr 26","doi":"10.1080/08897077.2020.1752351","keywords":["pandemic","buprenorphine","methadone","opioid use disorder","pharmacists","policy","regulations"],"source":"PubMed","topics":["Prevention"],"weight":1,"_version_":1664714520137826305,"score":8.518259,"similar":[{"pmid":32277732,"title":"A Primary Care Response to COVID-19 for Patients with an Opioid Use Disorder.","text":["A Primary Care Response to COVID-19 for Patients with an Opioid Use Disorder.","J Rural Health","Wilson, Courtenay Gilmore","Ramage, Melinda","Fagan, E Blake","32277732"],"journal":"J Rural Health","authors":["Wilson, Courtenay Gilmore","Ramage, Melinda","Fagan, E Blake"],"date":"2020-04-12T11:00:00Z","year":2020,"_id":"32277732","week":"202015|Apr 06 - Apr 12","doi":"10.1111/jrh.12438","keywords":["covid-19","buprenorphine/naloxone","opioid use disorder"],"source":"PubMed","topics":["Prevention"],"weight":1,"_version_":1664636943979249664,"score":162.44662},{"pmid":32307319,"title":"Medication management and adherence during the COVID-19 pandemic: Perspectives and experiences from low-and middle-income countries.","text":["Medication management and adherence during the COVID-19 pandemic: Perspectives and experiences from low-and middle-income countries.","The current coronavirus disease 2019 (COVID-19) pandemic is placing a huge strain on health systems worldwide. Suggested solutions like social distancing and lockdowns in some areas to help contain the spread of the virus may affect special patient populations like those with chronic illnesses who are unable to access healthcare facilities for their routine care and medicines management. Retail pharmacy outlets are the likely facilities for easy access by these patients. The contribution of community pharmacists in these facilities to manage chronic conditions and promote medication adherence during this COVID-19 pandemic will be essential in easing the burden on already strained health systems. This paper highlights the pharmaceutical care practices of community pharmacists for patients with chronic diseases during this pandemic. This would provide support for the call by the WHO to maintain essential services during the pandemic, in order to prevent non-COVID disease burden on healthcare systems particularly in low-and middle-income countries.","Res Social Adm Pharm","Kretchy, Irene A","Asiedu-Danso, Michelle","Kretchy, James-Paul","32307319"],"abstract":["The current coronavirus disease 2019 (COVID-19) pandemic is placing a huge strain on health systems worldwide. Suggested solutions like social distancing and lockdowns in some areas to help contain the spread of the virus may affect special patient populations like those with chronic illnesses who are unable to access healthcare facilities for their routine care and medicines management. Retail pharmacy outlets are the likely facilities for easy access by these patients. The contribution of community pharmacists in these facilities to manage chronic conditions and promote medication adherence during this COVID-19 pandemic will be essential in easing the burden on already strained health systems. This paper highlights the pharmaceutical care practices of community pharmacists for patients with chronic diseases during this pandemic. This would provide support for the call by the WHO to maintain essential services during the pandemic, in order to prevent non-COVID disease burden on healthcare systems particularly in low-and middle-income countries."],"journal":"Res Social Adm Pharm","authors":["Kretchy, Irene A","Asiedu-Danso, Michelle","Kretchy, James-Paul"],"date":"2020-04-21T11:00:00Z","year":2020,"_id":"32307319","week":"202017|Apr 20 - Apr 26","doi":"10.1016/j.sapharm.2020.04.007","keywords":["covid-19","chronic diseases","community pharmacists","lmics","medication adherence","pharmaceutical care"],"source":"PubMed","topics":["Prevention"],"weight":1,"_version_":1664632501487796226,"score":145.48839},{"pmid":32314954,"title":"COVID-19 Community Stabilization and Sustainability Framework: An Integration of the Maslow Hierarchy of Needs and Social Determinants of Health.","text":["COVID-19 Community Stabilization and Sustainability Framework: An Integration of the Maslow Hierarchy of Needs and Social Determinants of Health.","All levels of government are authorized to apply COVID-19 protection measures, however, they must consider how and when to ease lockdown restrictions to limit long-term societal harm and societal instability. Leaders that employ a well-considered framework with an incremental approach will be able to gradually restart society while simultaneously maintaining public health benefits achieved through lockdown measures. Economically vulnerable populations cannot endure long-term lockdown and most countries lack the ability to maintain a full nationwide relief operation. Decision-makers need to understand this risk and how the Maslow hierarchy of needs and the social determinants of health can guide whole of society policies. Aligning decisions with societal needs will help ensure all segments of society are catered for and met while managing the crisis. This must inform the process of incremental easing of lockdowns to facilitate the resumption of community foundations such as commerce, education and employment in a manner that protects those most vulnerable to COVID-19. This paper proposes a framework for identifying a path forward. It reflects on baseline requirements, regulations and recommendations, triggers, and implementation. Those desiring a successful recovery from the COVID-19 pandemic need to adopt an evidence-based framework now to ensure community stabilization and sustainability.","Disaster Med Public Health Prep","Ryan, Benjamin J","Coppola, Damon","Canyon, Deon V","Brickhouse, Mark","Swienton, Raymond","32314954"],"abstract":["All levels of government are authorized to apply COVID-19 protection measures, however, they must consider how and when to ease lockdown restrictions to limit long-term societal harm and societal instability. Leaders that employ a well-considered framework with an incremental approach will be able to gradually restart society while simultaneously maintaining public health benefits achieved through lockdown measures. Economically vulnerable populations cannot endure long-term lockdown and most countries lack the ability to maintain a full nationwide relief operation. Decision-makers need to understand this risk and how the Maslow hierarchy of needs and the social determinants of health can guide whole of society policies. Aligning decisions with societal needs will help ensure all segments of society are catered for and met while managing the crisis. This must inform the process of incremental easing of lockdowns to facilitate the resumption of community foundations such as commerce, education and employment in a manner that protects those most vulnerable to COVID-19. This paper proposes a framework for identifying a path forward. It reflects on baseline requirements, regulations and recommendations, triggers, and implementation. Those desiring a successful recovery from the COVID-19 pandemic need to adopt an evidence-based framework now to ensure community stabilization and sustainability."],"journal":"Disaster Med Public Health Prep","authors":["Ryan, Benjamin J","Coppola, Damon","Canyon, Deon V","Brickhouse, Mark","Swienton, Raymond"],"date":"2020-04-22T11:00:00Z","year":2020,"_id":"32314954","week":"202017|Apr 20 - Apr 26","doi":"10.1017/dmp.2020.109","keywords":["covid-19","public health","recovery","risk management","societies"],"source":"PubMed","topics":["Prevention"],"weight":1,"_version_":1664714520195497985,"score":144.29169},{"pmid":32249102,"title":"Recommendations and guidance for providing pharmaceutical care services during COVID-19 pandemic: A China perspective.","text":["Recommendations and guidance for providing pharmaceutical care services during COVID-19 pandemic: A China perspective.","BACKGROUND: The novel coronavirus pneumonia (COVID-19), which was first detected in Wuhan City, has now became a pandemic that affecting patients around the world. Particularly, the community patient population are at high risk of infection and are facing potential failure of proper medication use during the pandemic. OBJECTIVE: To discuss community pharmacists' role and the content of pharmaceutical care (PC) during the novel coronavirus pandemic to promote effective prevention and control and safe drug use of the community patient population. METHOD: Collect and summarize the experience Chinese community pharmacies gained from providing pharmacy services during the COVID-19 outbreak, and taking patients' PC needs into consideration, analyze and discuss the methods and strategies that community pharmacies and pharmacists shall use to provide PC during the pandemic. RESULTS: Community pharmacy management teams shall support PC services by providing adequate supply of COVID-19 related medications and preventative products, following environment regulations, and providing sufficient staff trainings. Pharmacists shall use various approaches to provide PC services in drug dispensing, consulting and referrals, chronic disease management, safe use of infusions, patient education, home care guidance and psychological support to promote the COVID-19 pandemic control and ensure safe medication use of community patients during the pandemic. CONCLUSION: PC services in communities during the COVID-19 shall possess different properties due to disease characteristics and related change in patients' need. Community pharmacies shall work as a strong supporter of patient's medication and protective equipment supply. Community pharmacists shall be prepared to provide skilled and effective PC services for community patient population to ensure medication safety and promote the overall COVID-19 pandemic control.","Res Social Adm Pharm","Zheng, Si-Qian","Yang, Li","Zhou, Peng-Xiang","Li, Hui-Bo","Liu, Fang","Zhao, Rong-Sheng","32249102"],"abstract":["BACKGROUND: The novel coronavirus pneumonia (COVID-19), which was first detected in Wuhan City, has now became a pandemic that affecting patients around the world. Particularly, the community patient population are at high risk of infection and are facing potential failure of proper medication use during the pandemic. OBJECTIVE: To discuss community pharmacists' role and the content of pharmaceutical care (PC) during the novel coronavirus pandemic to promote effective prevention and control and safe drug use of the community patient population. METHOD: Collect and summarize the experience Chinese community pharmacies gained from providing pharmacy services during the COVID-19 outbreak, and taking patients' PC needs into consideration, analyze and discuss the methods and strategies that community pharmacies and pharmacists shall use to provide PC during the pandemic. RESULTS: Community pharmacy management teams shall support PC services by providing adequate supply of COVID-19 related medications and preventative products, following environment regulations, and providing sufficient staff trainings. Pharmacists shall use various approaches to provide PC services in drug dispensing, consulting and referrals, chronic disease management, safe use of infusions, patient education, home care guidance and psychological support to promote the COVID-19 pandemic control and ensure safe medication use of community patients during the pandemic. CONCLUSION: PC services in communities during the COVID-19 shall possess different properties due to disease characteristics and related change in patients' need. Community pharmacies shall work as a strong supporter of patient's medication and protective equipment supply. Community pharmacists shall be prepared to provide skilled and effective PC services for community patient population to ensure medication safety and promote the overall COVID-19 pandemic control."],"journal":"Res Social Adm Pharm","authors":["Zheng, Si-Qian","Yang, Li","Zhou, Peng-Xiang","Li, Hui-Bo","Liu, Fang","Zhao, Rong-Sheng"],"date":"2020-04-07T11:00:00Z","year":2020,"_id":"32249102","week":"202015|Apr 06 - Apr 12","doi":"10.1016/j.sapharm.2020.03.012","keywords":["COVID-19","Community pharmacy","Novel coronavirus pneumonia","Pharmaceutical care","Safe medication use"],"source":"PubMed","locations":["Chinese","Wuhan","China","Pharmacists"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Prevention"],"weight":1,"_version_":1663352136248852481,"score":135.93103},{"pmid":32240484,"pmcid":"PMC7113541","title":"Providing pharmacy services at cabin hospitals at the coronavirus epicenter in China.","text":["Providing pharmacy services at cabin hospitals at the coronavirus epicenter in China.","In the Chinese coronavirus epicenter, Wuhan, 16 cabin hospitals were built to admit patients with confirmed coronavirus infection (COVID-19). These cabin hospitals serve the role of effectively quarantine and treat mild cases of patients infected with COVID-19. Each cabin hospital has pharmacists to provide services and pharmaceutical care to patients. Pharmacists also provide assistance to cabin hospitals through remote internet platforms across China. In this commentary, we describe pharmacy services at cabin hospitals to share our experiences with the international pharmacy community.","Int J Clin Pharm","Meng, Long","Qiu, Feng","Sun, Shusen","32240484"],"abstract":["In the Chinese coronavirus epicenter, Wuhan, 16 cabin hospitals were built to admit patients with confirmed coronavirus infection (COVID-19). These cabin hospitals serve the role of effectively quarantine and treat mild cases of patients infected with COVID-19. Each cabin hospital has pharmacists to provide services and pharmaceutical care to patients. Pharmacists also provide assistance to cabin hospitals through remote internet platforms across China. In this commentary, we describe pharmacy services at cabin hospitals to share our experiences with the international pharmacy community."],"journal":"Int J Clin Pharm","authors":["Meng, Long","Qiu, Feng","Sun, Shusen"],"date":"2020-04-03T11:00:00Z","year":2020,"_id":"32240484","week":"202014|Mar 30 - Apr 05","doi":"10.1007/s11096-020-01020-5","keywords":["covid-19","cabin hospital","china","pharmaceutical care","pharmacists","pharmacy service"],"source":"PubMed","topics":["Prevention"],"weight":1,"locations":["Chinese","Wuhan","China","China"],"countries":["China"],"countries_codes":["CHN|China"],"_version_":1664638354191286272,"score":129.87119}]}